Table 3.
Variable | Post-chemotherapy (n = 46) | Baseline (n = 46) | Mean Change | Mean % Change | P-value |
---|---|---|---|---|---|
3D EF (%) | 58.48 ± 4.89 | 60.63 ± 4.71 | −2.15 | −3.55% | <0.001 |
3D EDV (ml) | 88.02 ± 15.24 | 85.44 ± 14.97 | 2.58 | 3.02% | 0.010 |
3D ESV (ml) | 35.82 ± 9.80 | 33.83 ± 9.70 | 1.99 | 5.88% | 0.005 |
3D GLS (%) | −9.85 ± 2.14 | −13.91 ± 2.16 | −4.06 | −29.19% | <0.001 |
3D GCS (%) | −9.98 ± 3.64 | −14.39 ± 4.28 | −4.41 | −30.65% | <0.001 |
3D GAS (%) | −15.78 ± 2.91 | −20.13 ± 2.73 | −4.35 | −21.61% | <0.001 |
3D GRS (%) | 20.80 ± 6.97 | 29.57 ± 5.00 | −8.77 | −29.66% | <0.001 |
EF – ejection fraction; EDV – end-diastolic volume; ESV – end-systolic volume; GLS – global longitudinal strain; GCS – global circumferential strain; GAS – global area strain; GRS – global radial strain.